You have probably heard the term “regenerative medicine” from a friend who recovered from a stubborn knee injury, or from a video about a professional athlete returning to sport faster than expected. Perhaps your doctor mentioned PRP, or you stumbled across something called BPC-157 in a health forum. The terms can be confusing — and the claims, sometimes overwhelming.
This article explains, in plain language, what the major regenerative injection therapies are, what they actually do inside your body, where the science currently stands, and which conditions they are most suited for. The goal is not to sell you any treatment. The goal is to help you have a smarter, more informed conversation with your doctor.
Regenerative medicine works on a simple but powerful idea: instead of suppressing pain with medication or replacing a joint with metal and plastic, we can use the body’s own biological materials — blood, bone marrow, fat tissue — to stimulate genuine healing. The results are not guaranteed, and the evidence base varies by therapy and condition. But for many patients who have exhausted conventional options, these approaches offer something genuinely new.
Part 1: Autologous Injections — Your Own Biology as Medicine
“Autologous” means the treatment comes from your own body. No donor, no synthetic drug, no foreign material. This dramatically reduces the risk of rejection or allergic reaction, which is one reason these therapies have attracted significant research interest.
Platelet-Rich Plasma (PRP)
What It Is
Blood is drawn from your arm — usually 15 to 60 ml, roughly the same as a standard blood test. It is then placed in a centrifuge, a machine that spins at high speed to separate blood into its components. The result is a concentrated layer of platelets, the tiny blood cells responsible for clotting and, crucially, for releasing growth factors that trigger tissue repair.
This platelet-rich layer is collected and injected directly into the injured area, guided by ultrasound in careful clinical practice.
What Platelets Actually Do
Platelets are not just clotting agents. When activated, they release a cascade of growth factors, including:
- PDGF (Platelet-Derived Growth Factor) — stimulates cell proliferation and new blood vessel formation
- TGF-β (Transforming Growth Factor Beta) — regulates inflammation and promotes collagen synthesis
- VEGF (Vascular Endothelial Growth Factor) — drives angiogenesis, the creation of new blood supply to healing tissue
- IGF-1 (Insulin-Like Growth Factor 1) — supports muscle and tendon repair
- EGF (Epidermal Growth Factor) — promotes cell growth and tissue regeneration
When this concentrated signal is delivered to a damaged tendon, joint, or muscle, it essentially amplifies the body’s natural healing response.
Where PRP Is Used
PRP has the broadest evidence base of all regenerative injections. Its most well-supported applications include:
- Knee osteoarthritis — Extensive research, including multiple Level 1 randomised controlled trials, consistently shows PRP outperforms hyaluronic acid (viscosupplementation) for pain reduction and functional improvement in mild to moderate knee OA.
- Lateral epicondylitis (Tennis Elbow) — One of the earliest and most robust indications. Studies show PRP produces superior long-term pain relief compared to corticosteroid injection, particularly at 6-month and 12-month follow-up.
- Plantar fasciitis — Multiple trials show meaningful reductions in pain and improvements in function, with effects lasting 6–12 months or longer.
- Achilles tendinopathy — Moderate evidence, particularly for mid-portion Achilles tendinopathy that has not responded to eccentric loading programs.
- Patellar tendinopathy (Jumper’s Knee) — Good outcomes in athletes, with improved function and return-to-sport timelines.
- Rotator cuff tears — Evidence is mixed; benefit for partial tears and as an adjunct to surgical repair, but not a substitute for surgery in large structural tears.
- Androgenic alopecia (Hair loss) — Now a mainstream option; controlled studies confirm improved hair density, thickness, and follicular survival.
- Chronic wounds and diabetic ulcers — PRP accelerates granulation tissue formation and epithelialisation.
What PRP Cannot Do
PRP is not a cure for advanced arthritis where cartilage is completely absent. It does not regenerate bone. It is unlikely to help in large, retracted tendon tears. And because platelet concentration and preparation methods vary widely between clinics, outcomes can be inconsistent unless the practitioner follows validated protocols.
Current Evidence Rating: Moderate to Strong for knee OA, tendinopathies, and hair loss. Moderate for rotator cuff. Emerging for other applications.
GFC — Growth Factor Concentrate
What It Is
GFC, or Growth Factor Concentrate, is a more refined evolution of PRP. The same centrifugation principle applies, but the process is designed to extract a higher concentration of growth factors with minimal red and white blood cells.
Standard PRP contains platelets, white blood cells (leukocytes), and red blood cells in varying proportions — and research increasingly suggests that high leukocyte content may actually increase post-injection inflammation in some tissues. GFC aims to deliver a purer growth factor payload with reduced cellular debris.
Where GFC Is Used
GFC has been most studied in androgenic alopecia (with equal or superior results to standard PRP for hair regrowth and better tolerability), facial rejuvenation and skin quality, and — more recently — musculoskeletal applications where early results align with PRP data with potentially reduced post-injection flare.
Current Evidence Rating: Moderate to Strong for hair loss. Emerging for orthopaedic applications.
BMAC — Bone Marrow Aspirate Concentrate
What It Is
BMAC is a step up in biological complexity from PRP. Rather than drawing blood, the clinician uses a special needle to aspirate bone marrow — most commonly from the posterior iliac crest (the back of your pelvic bone), under local anaesthesia. The aspirate is centrifuged to concentrate mesenchymal stem cells (MSCs), haematopoietic progenitor cells, growth factors including bone morphogenetic proteins (BMPs), and cytokines.
Where BMAC Is Used
BMAC’s strength lies in conditions requiring genuine tissue regeneration: cartilage defects and early-to-moderate osteoarthritis; avascular necrosis (AVN) of the femoral head (one of the most evidence-supported indications, often combined with core decompression); bone healing and non-union fractures; rotator cuff repair as a surgical adjunct; and complex tendinopathies that have failed PRP.
Current Evidence Rating: Moderate to Strong for AVN. Moderate for knee OA and cartilage defects. Early/Emerging for other musculoskeletal applications.
Adipose-Derived Stem Cell Therapy (SVF)
What It Is
Body fat is a rich source of regenerative cells. A small amount of fat is harvested via a mini-lipoaspiration procedure and processed to yield the Stromal Vascular Fraction (SVF) — a mixture of adipose-derived MSCs, pericytes, endothelial progenitor cells, regulatory immune cells and growth factors. Fat contains far more MSCs per unit volume than bone marrow.
Where Fat-Derived Stem Cells Are Used
Moderate to severe knee osteoarthritis (significant pain reduction and functional improvement, with some evidence of cartilage protection), hip and shoulder OA, autoimmune and systemic inflammatory conditions (investigational), and aesthetic applications. In India, minimally manipulated same-day SVF is permitted under ICMR guidelines for certain orthopaedic indications within approved settings.
Current Evidence Rating: Moderate for knee OA. Early/Emerging for other applications.
Part 2: Peptide Injections — The Emerging Frontier
Peptides are short chains of amino acids capable of sending very specific biological signals. Two — BPC-157 and TB-500 — have become widely discussed among athletes and patients with chronic tissue injuries.
A critical note: neither BPC-157 nor TB-500 is currently approved by the US FDA, European EMA, or CDSCO for human therapeutic use. They remain in the research phase. This section presents what the available science says — not a clinical recommendation.
BPC-157 — Body Protection Compound
BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice, studied for over three decades at the University of Zagreb. It acts through VEGF upregulation (angiogenesis), nitric oxide modulation, growth-hormone receptor interactions, gut-brain axis regulation, and tendon-to-bone healing. The majority of research is in animal models, where results are striking — but there are no completed, published Phase 2 or Phase 3 human RCTs at the time of writing. The theoretical basis is sound and many athletes report benefit, but rigorous human evidence does not yet exist in the public domain. In animal studies its safety profile is remarkable, but long-term human safety data is lacking.
TB-500 — Thymosin Beta-4 (Synthetic Analogue)
Thymosin Beta-4 is a naturally occurring peptide found in nearly every cell, central to actin regulation, anti-inflammatory activity, stem cell activation, angiogenesis, and cardiac regeneration. TB-500 is a synthetic fragment corresponding to its actin-binding region, used commercially in veterinary (racehorse) contexts. Like BPC-157, its evidence base is predominantly preclinical; human musculoskeletal trial data is essentially absent. The two are frequently stacked on the basis of complementary mechanisms, though clinical evidence for the combination does not exist in published form.
Part 3: Choosing the Right Regenerative Approach
These therapies are not interchangeable. Each is biologically distinct, with a different risk and invasiveness profile, and is better or worse suited to different clinical problems. As a simplified guide: PRP (or GFC) for mild-moderate knee OA, tendinopathy and hair loss; BMAC for chronic tendinopathy resistant to PRP, cartilage defects and AVN; SVF for moderate-severe OA and systemic inflammation; and peptides only in an experimental context under medical supervision. A trained regenerative physician will assess imaging, severity, health status, prior treatment and your goals before recommending any option. Most programmes involve 2–3 injections over weeks to months, combined with rehabilitation.
Frequently Asked Questions
Are these treatments painful?
The injections range from mildly uncomfortable (PRP from a blood draw) to more significant (BMAC aspiration), all performed with local anaesthesia. Post-injection soreness lasting 24–72 hours is common with PRP and BMAC — it reflects the healing cascade. Most patients return to light activity within 2–3 days.
How many sessions are needed?
PRP for tendinopathy or OA typically involves 2–3 injections spaced 4–6 weeks apart. Hair loss protocols often use monthly sessions for 3 months, then maintenance. BMAC and SVF are usually single procedures. Your clinician designs the protocol based on imaging, severity, and response.
How long before results are seen?
Unlike corticosteroids, there is no immediate relief — tissue healing takes time. Most patients notice early improvement at 4–6 weeks, more meaningful change at 3 months, and full results assessed at 6–12 months. Active rehabilitation during this period is essential.
Are these treatments covered by insurance in India?
Currently most regenerative injection therapies (PRP, GFC, BMAC, SVF) are not covered under standard health insurance in India and are offered on a cash-pay basis. Check your specific policy terms.
Are peptide injections like BPC-157 and TB-500 safe?
Available animal data suggests a favourable safety profile, but long-term human safety data is not available and these peptides are not approved for human use in most countries. They should only be considered under the direct supervision of a physician familiar with the current evidence and transparent about their investigational status.
Can regenerative injections replace surgery?
In some cases, yes — PRP and BMAC have helped patients avoid or delay joint replacement, and BMAC is a recognised alternative in early AVN. However, for large structural tears or bone-on-bone arthritis, surgery may remain most appropriate. Regenerative medicine works best when there is still viable tissue to regenerate.
A Note on Seeking Treatment
Seek evaluation from a physician who combines expertise in musculoskeletal or sports medicine with training in regenerative techniques. Ask for your imaging to be reviewed before any treatment decision. Understand that outcomes vary, preparation protocols matter, and rehabilitation is non-negotiable.
This article is for patient education purposes only and does not constitute medical advice. Please consult a qualified physician before pursuing any regenerative injection therapy.
About the Author
Dr. Ajeesh T Alex
BAMS (Reg. No. TCMC13868)
IOC Diploma in Sports Nutrition | Master Diplomate of Dry Needling, IAODN — Myotatic Approach | Certified Kinesiology Taping Practitioner | Certified Manual Therapist | Certified in Elemental Acupuncture
Former Medical Officer, Sports Ayurveda Research Cell, Thodupuzha Government Ayurveda Hospital
Founder & Chief Physician, ACTYMED HEALTHCARE — Thodupuzha · Perumbavoor · Kottarakkara
Founder – ACTYMED PERFORMANCE NUTRITION